CF
Cantor Fitzgerald Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
376
Grid Dynamics Holdings
GDYN
$662M
|
JS
Josh Siegler
| $7.82 | $17 |
117%
upside
| Overweight |
13 Mar ‘24
1 year ago |
|
377
Inspirato
ISPO
$39.4M
|
BK
Brett Knoblauch
| $3.16 | $18 |
470%
upside
| Overweight |
7 Mar ‘24
1 year ago |
|
378
PagSeguro Digital
PAGS
$2.8B
|
JS
Josh Siegler
| $9.60 | $16 |
67%
upside
| Overweight |
4 Mar ‘24
1 year ago |
|
379
TruBridge
TBRG
$300M
|
SH
Steven Halper
| $19.98 | $24 |
20%
upside
| Overweight |
1 Mar ‘24
1 year ago |
|
380
Payoneer
PAYO
$2.4B
|
JS
Josh Siegler
| $6.65 | $7 |
5%
upside
| Overweight |
1 Mar ‘24
1 year ago |
|
381
Array Technologies
ARRY
$1.37B
|
DS
Derek Soderberg
| $8.97 | $18 |
101%
upside
| Overweight |
28 Feb ‘24
1 year ago |
|
382
Genius Sports
GENI
$3.22B
|
BK
Brett Knoblauch
| $13.50 | $8 |
41%
downside
| Overweight |
26 Feb ‘24
1 year ago |
|
383
Root
ROOT
$1.43B
|
JS
Josh Siegler
| $92.64 | $13 |
86%
downside
| Overweight |
22 Feb ‘24
1 year ago |
|
384
Lineage Cell Therapeutics
LCTX
$279M
|
KK
Kristen Kluska
| $1.22 | $6 |
392%
upside
| Overweight |
5 Feb ‘24
1 year ago |
|
385
Rocket Pharmaceuticals
RCKT
$354M
|
LC
Louise Chen
| $3.28 | $65 |
1,882%
upside
| Overweight |
31 Jan ‘24
1 year ago |
|
386
Teradyne
TER
$19.1B
| $120.20 | $110 |
8%
downside
| Neutral |
23 Jan ‘24
1 year ago |
|
|
387
Microvast
MVST
$829M
|
DS
Derek Soderberg
| $2.56 | $8 |
213%
upside
| Overweight |
13 Dec ‘23
1 year ago |
|
388
REE Automotive
REE
$18.9M
|
AS
Andres Sheppard
| $0.6708 | $4 |
496%
upside
| Underweight |
1 Dec ‘23
1 year ago |
|
389
Marti Technologies
MRT
$190M
|
BK
Brett Knoblauch
| $2.41 | $0.9000 |
63%
downside
| Overweight |
29 Nov ‘23
1 year ago |
|
390
SELLAS Life Sciences
SLS
$201M
|
LW
Li Watsek
| $1.91 | $3 |
57%
upside
| Overweight |
22 Nov ‘23
1 year ago |
|
391
StoneCo
STNE
$4.63B
|
JS
Josh Siegler
| $17.30 | $21 |
21%
upside
| Overweight |
16 Nov ‘23
1 year ago |
|
392
Mirum Pharmaceuticals
MIRM
$3.82B
|
JS
Joshua Schimmer
| $76.06 | $50 |
34%
downside
| Overweight |
15 Nov ‘23
1 year ago |
|
393
Crinetics Pharmaceuticals
CRNX
$3.35B
|
CD
Charles Duncan
| $35.61 | $50 |
40%
upside
| Overweight |
24 Oct ‘23
1 year ago |
|
394
Vertex Pharmaceuticals
VRTX
$102B
|
ES
Eric Schmidt
| $396.12 | $370 |
7%
downside
| Overweight |
17 Oct ‘23
1 year ago |
|
395
Regeneron Pharmaceuticals
REGN
$60.8B
|
AY
Alethia Young
| $573.38 | $850 |
48%
upside
| Neutral |
16 Oct ‘23
1 year ago |
|
396
Hyliion Holdings
HYLN
$309M
|
AS
Andres Sheppard
| $1.76 | $1 |
43%
downside
| Underweight |
12 Oct ‘23
1 year ago |
|
397
Sanara MedTech
SMTI
$299M
|
BF
Brandon Folkes
| $33.57 | $59 |
76%
upside
| Overweight |
26 Sep ‘23
1 year ago |
|
|
NYXH
398
Nyxoah
NYXH
$223M
|
SH
Steven Halper
| $5.93 | $11 |
86%
upside
| Overweight |
26 Sep ‘23
1 year ago |
|
399
Nano X Imaging
NNOX
$236M
|
SH
Steven Halper
| $3.69 | $30 |
713%
upside
| Overweight |
26 Sep ‘23
1 year ago |
|
400
Solid Biosciences
SLDB
$428M
|
CD
Charles Duncan
| $5.50 | $5 |
9%
downside
| Overweight |
22 Sep ‘23
1 year ago |
|